Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
6/26/26 Nippon (4516) deramiocel for Duchenne Muscular Dystrophy (DMD) Subscribers Only Subscribers Only Subscribers Only
6/23/26 Sanofi (SNY) Wayrilz for Immune Thrombocytopenic Purpura (ITP) Subscribers Only Subscribers Only Subscribers Only
6/23/26 Corxel Pharmaceuticals VCT 220 for Obesity Subscribers Only Subscribers Only Subscribers Only
6/22/26 Achieve Life Sciences (ACHV) Tabex for Smoking Cessation Subscribers Only Subscribers Only Subscribers Only
6/22/26 Eledon Pharmaceuticals (ELDN) tegoprubart for Kidney Transplant Rejection Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/26/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/08/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/17/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update